{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:13:31Z","timestamp":1790536411243,"version":"4.1.0"},"reference-count":123,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>B-cell lymphomas exhibit a vast variety of clinical and histological characteristics that might complicate the diagnosis. Timely diagnosis is crucial, as treatments for aggressive subtypes are considered successful and frequently curative, whereas indolent B-cell lymphomas are incurable and often need several therapies. The purpose of this review is to explore the current advancements achieved in B-cell lymphomas metabolism and how these indicators help to early detect metabolic changes in B-cell lymphomas and the use of predictive biological markers in refractory or relapsed disease. Since the year 1920, the Warburg effect has been known as an integral part of metabolic reprogramming. Compared to normal cells, cancerous cells require more glucose. These cancer cells undergo aerobic glycolysis instead of oxidative phosphorylation to metabolize glucose and form lactate as an end product. With the help of these metabolic alterations, a novel biomass is generated by the formation of various precursors. An aggressive metabolic phenotype is an aerobic glycolysis that has the advantage of producing high-rate ATP and preparing the biomass for the amino acid, as well as fatty acid, synthesis needed for a rapid proliferation of cells, while aerobic glycolysis is commonly thought to be the dominant metabolism in cancer cells. Later on, many metabolic biomarkers, such as increased levels of lactate dehydrogenase (LDH), plasma lactate, and deficiency of thiamine in B-cell lymphoma patients, were discovered. Various kinds of molecules can be used as biomarkers, such as genes, proteins, or hormones, because they all refer to body health. Here, we focus only on significant metabolic biomarkers in B-cell lymphomas. In conclusion, many metabolic biomarkers have been shown to have clinical validity, but many others have not been subjected to extensive testing to demonstrate their clinical usefulness in B-cell lymphoma. Furthermore, they play an essential role in the discovery of new therapeutic targets.<\/jats:p>","DOI":"10.3390\/diagnostics12020394","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:35:17Z","timestamp":1643974517000},"page":"394","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Metabolic Biomarkers in B-Cell Lymphomas for Early Diagnosis and Prediction, as Well as Their Influence on Prognosis and Treatment"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0747-9451","authenticated-orcid":false,"given":"Abdullah","family":"Alfaifi","sequence":"first","affiliation":[{"name":"Department of Biological Science, Faculty of Science, King AbdulAziz University, Jeddah 21589, Saudi Arabia"},{"name":"Fayfa General Hospital, Ministry of Health, Jazan 83581, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem","family":"Bahashwan","sequence":"additional","affiliation":[{"name":"Hematology Research Unit, King Fahad Medical Research Center, King AbdulAziz University, Jeddah 21589, Saudi Arabia"},{"name":"Department of Hematology, Faculty of Medicine, King AbdulAziz University, Jeddah 21589, Saudi Arabia"},{"name":"King AbdulAziz University Hospital, King AbdulAziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-2696","authenticated-orcid":false,"given":"Mohammed","family":"Alsaadi","sequence":"additional","affiliation":[{"name":"Department of Biological Science, Faculty of Science, King AbdulAziz University, Jeddah 21589, Saudi Arabia"},{"name":"Hematology Research Unit, King Fahad Medical Research Center, King AbdulAziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz","family":"Malhan","sequence":"additional","affiliation":[{"name":"Prince Mohammed Bin Nasser Hospital, Ministry of Health, Jazan 82943, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-1366","authenticated-orcid":false,"given":"Aqeel","family":"Aqeel","sequence":"additional","affiliation":[{"name":"Prince Mohammed Bin Nasser Hospital, Ministry of Health, Jazan 82943, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waiel","family":"Al-Kahiry","sequence":"additional","affiliation":[{"name":"Prince Mohammed Bin Nasser Hospital, Ministry of Health, Jazan 82943, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Almehdar","sequence":"additional","affiliation":[{"name":"Department of Biological Science, Faculty of Science, King AbdulAziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-0585","authenticated-orcid":false,"given":"Ishtiaq","family":"Qadri","sequence":"additional","affiliation":[{"name":"Department of Biological Science, Faculty of Science, King AbdulAziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin Lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13402-019-00426-2","article-title":"Clinical Significance of Metabolism-Related Biomarkers in Non-Hodgkin Lymphoma\u2014MCT1 as Potential Target in Diffuse Large B Cell Lymphoma","volume":"42","author":"Afonso","year":"2019","journal-title":"Cell. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin Lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"key":"ref_4","first-page":"2375","article-title":"The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_5","first-page":"209","article-title":"Applications of Metabolomics in Cancer Studies","volume":"965","author":"Armitage","year":"2017","journal-title":"Metab. Fundam. Clin. Appl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4161\/cbt.12.11.18140","article-title":"Tumor Cell Metabolism: An Integral View","volume":"12","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrc2817","article-title":"Targeting Metabolic Transformation for Cancer Therapy","volume":"10","author":"Tennant","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4062\/biomolther.2017.211","article-title":"Oncogene-Driven Metabolic Alterations in Cancer","volume":"26","author":"Min","year":"2018","journal-title":"Biomol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/febs.14125","article-title":"Metabolic Rewiring in Mutant Kras Lung Cancer","volume":"285","author":"Kerr","year":"2018","journal-title":"FEBS J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.20517\/2394-4722.2019.05","article-title":"Metabolic Alterations and the Potential for Targeting Metabolic Pathways in the Treatment of Multiple Myeloma","volume":"2019","author":"Rizzieri","year":"2019","journal-title":"J. Cancer Metastasis Treat."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Park, J., Shin, Y., Kim, T.H., Kim, D.H., and Lee, A. (2019). Plasma Metabolites as Possible Biomarkers for Diagnosis of Breast Cancer. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225129"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Park, J.H., Pyun, W.Y., and Park, H.W. (2020). Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets. Cells, 9.","DOI":"10.3390\/cells9102308"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of Cancer Metabolism","volume":"2","author":"Chandel","year":"2016","journal-title":"Sci. Adv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","article-title":"Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in b Cells","volume":"15","author":"Le","year":"2012","journal-title":"Cell Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3324\/haematol.2016.163030","article-title":"Inhibition of Monocarboxyate Transporter 1 by AZD3965 as a Novel Therapeutic Approach for Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma","volume":"102","author":"Noble","year":"2017","journal-title":"Haematologica"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1477-3163.113622","article-title":"Applications of Metabolomics in Cancer Research","volume":"12","author":"Styczynski","year":"2013","journal-title":"J. Carcinog."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2013-03-493163","article-title":"Inhibiting Glutamine Uptake Represents an Attractive New Strategy for Treating Acute Myeloid Leukemia","volume":"122","author":"Willems","year":"2013","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/bs.acc.2019.11.002","article-title":"New Biomarkers in Non-Hodgkin Lymphoma and Acute Leukemias","volume":"96","year":"2020","journal-title":"Adv. Clin. Chem."},{"key":"ref_19","first-page":"1","article-title":"Cancer Biology-Causes & Biomarkers of Cancer","volume":"2019","author":"Bansode","year":"2019","journal-title":"Curr. Res. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fonc.2018.00556","article-title":"Metabolic Reprogramming of Non-Hodgkin\u2019s B-Cell Lymphomas and Potential Therapeutic Strategies","volume":"8","author":"Ricci","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3892\/ol.2012.928","article-title":"Energy Metabolism of Cancer: Glycolysis versus Oxidative Phosphorylation (Review)","volume":"4","author":"Zheng","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3389\/fmicb.2018.01233","article-title":"Epstein-Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas","volume":"9","author":"Piccaluga","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does It Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s Contributions to Current Concepts of Cancer Metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.gendis.2017.02.003","article-title":"Aerobic Glycolysis and High Level of Lactate in Cancer Metabolism and Microenvironment","volume":"4","author":"Jiang","year":"2017","journal-title":"Genes Dis."},{"key":"ref_26","first-page":"1","article-title":"Cancer Metabolic Reprogramming: Importance, Main Features, and Potentials for Precise Targeted Anti-Cancer Therapies","volume":"11","author":"Phan","year":"2014","journal-title":"Cancer Biol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-16-2074","article-title":"Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation","volume":"77","author":"Yu","year":"2017","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrc.2016.82","article-title":"Metabolic Control of Epigenetics in Cancer","volume":"16","author":"Kinnaird","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1242454","article-title":"Fueling Immunity: Insights into Metabolism and Lymphocyte Function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"594782","DOI":"10.3389\/fonc.2020.594782","article-title":"Linking Immunoevasion and Metabolic Reprogramming in B-Cell\u2013Derived Lymphomas","volume":"10","author":"Baur","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12291-015-0511-3","article-title":"Serum Lactate Dehydrogenase in Non-Hodgkin\u2019s Lymphoma: A Prognostic Indicator","volume":"31","author":"Yadav","year":"2016","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","first-page":"25","article-title":"Type B Lactic Acidosis: A Rare but Life Threatening Hematologic Emergency. A Case Illustration and Brief Review","volume":"5","author":"Claudino","year":"2015","journal-title":"Am. J. Blood Res."},{"key":"ref_34","first-page":"120","article-title":"Type B Lactic Acidosis in Solid Malignancies","volume":"69","author":"Sprenger","year":"2011","journal-title":"Neth. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1100\/tsw.2011.125","article-title":"Type B Lactic Acidosis Secondary to Malignancy: Case Report, Review of Published Cases, Insights into Pathogenesis, and Prospects for Therapy","volume":"11","author":"Ruiz","year":"2011","journal-title":"Sci. World J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.mayocp.2013.06.012","article-title":"Etiology and Therapeutic Approach to Elevated Lactate Levels","volume":"88","author":"Andersen","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/j.ajkd.2013.03.036","article-title":"Type B Lactic Acidosis Associated with Multiple Myeloma","volume":"62","author":"Sia","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","article-title":"Clinical Applications of Metabolomics in Oncology: A Review","volume":"15","author":"Spratlin","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00204-010-0609-6","article-title":"The Role of Metabolites and Metabolomics in Clinically Applicable Biomarkers of Disease","volume":"85","author":"Mamas","year":"2011","journal-title":"Arch. Toxicol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Barberini, L., Noto, A., Fattuoni, C., Satta, G., Zucca, M., Cabras, M.G., Mura, E., and Cocco, P. (2019). The Metabolomic Profile of Lymphoma Subtypes: A Pilot Study. Molecules, 24.","DOI":"10.3390\/molecules24132367"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/HCG.0000000000000032","article-title":"Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement from the American Heart Association","volume":"10","author":"Cheng","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1073\/pnas.1205995109","article-title":"Dysregulation of Fatty Acid Synthesis and Glycolysis in Non-Hodgkin Lymphoma","volume":"109","author":"Bhatt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","article-title":"Diagnostic and Prognostic Impact of 18F-FDG PET\/CT in Follicular Lymphoma","volume":"37","author":"Bayat","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1148\/rg.301095088","article-title":"FDG PET\/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease","volume":"30","author":"Paes","year":"2010","journal-title":"Radiographics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","article-title":"Intensity of 18fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes between Indolent and Aggressive Non-Hodgkin\u2019s Lymphoma","volume":"23","author":"Noy","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s12185-011-0822-y","article-title":"High Maximum Standard Uptake Value (SUVmax) on PET Scan Is Associated with Shorter Survival in Patients with Diffuse Large B Cell Lymphoma","volume":"93","author":"Chihara","year":"2011","journal-title":"Int. J. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/nbm.2825","article-title":"Decreased Lactate Concentration and Glycolytic Enzyme Expression Reflect Inhibition of MTOR Signal Transduction Pathway in B-Cell Lymphoma","volume":"26","author":"Lee","year":"2013","journal-title":"NMR Biomed."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plipres.2016.03.005","article-title":"Choline Kinase Alpha\u2014Putting the ChoK-Hold on Tumor Metabolism","volume":"63","author":"Arlauckas","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1590\/1806-9282.63.02.109","article-title":"Targeting Personalized Medicine in a Non-Hodgkin Lymphoma Patient with 18F-FDG and 18F-Choline PET\/CT","volume":"63","author":"Ribeiro","year":"2017","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Gokhale, S., and Xie, P. (2021). Chok-Full of Potential: Choline Kinase in b Cell and t Cell Malignancies. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13060911"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the Origin of Cancer Cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_52","first-page":"207","article-title":"An Improved Prognostic Parameter for Non-Hodgkin\u2019s Lymphoma Based on the Combination of Three Serum Tumor Markers","volume":"23","author":"Gui","year":"2008","journal-title":"Int. J. Biol. Markers"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10330-009-0033-7","article-title":"Prognostic Values of Serum LDH and \u03922-MG in Patients with Non-Hodgkin\u2019s Lymphoma","volume":"8","author":"Yang","year":"2009","journal-title":"Chin.-Ger. J. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"677763","DOI":"10.3389\/fonc.2021.677763","article-title":"NEK2 Promotes Cell Proliferation and Glycolysis by Regulating PKM2 Abundance via Phosphorylation in Diffuse Large B-Cell Lymphoma","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"621082","DOI":"10.1155\/2014\/621082","article-title":"Nek2 Is a Novel Regulator of B Cell Development and Immunological Response","volume":"2014","author":"Gu","year":"2014","journal-title":"Biomed Res. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-62703-429-6_14","article-title":"Studying Myc\u2019s Role in Metabolism Regulation","volume":"1012","author":"Le","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.semcdb.2012.01.005","article-title":"Autophagy and Cancer Cell Metabolism","volume":"23","author":"Lozy","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.7150\/jca.24331","article-title":"B Cell Lymphoma with Different Metabolic Characteristics Show Distinct Sensitivities to Metabolic Inhibitors","volume":"9","author":"Liu","year":"2018","journal-title":"J. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41598-018-19182-8","article-title":"Role of Hypoxia in Diffuse Large B-Cell Lymphoma: Metabolic Repression and Selective Translation of HK2 Facilitates Development of DLBCL","volume":"8","author":"Bhalla","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ambrosio, M.R., Piccaluga, P.P., Ponzoni, M., Rocca, B.J., Malagnino, V., Onorati, M., De Falco, G., Calbi, V., Ogwang, M., and Naresh, K.N. (2012). The Alteration of Lipid Metabolism in Burkitt Lymphoma Identifies a Novel Marker: Adipophilin. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044315"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fonc.2018.00550","article-title":"The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies","volume":"8","author":"Arruga","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1349-7006.2009.01130.x","article-title":"Gain-of-Function Mutations and Copy Number Increases of Notch2 in Diffuse Large B-Cell Lymphoma","volume":"100","author":"Lee","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1182\/blood-2013-12-546309","article-title":"Exome Sequencing Reveals Novel Mutation Targets in Diffuse Large B-Cell Lymphomas Derived from Chinese Patients","volume":"124","author":"Georgiou","year":"2014","journal-title":"Blood"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.leukres.2016.08.002","article-title":"The Metabolomic Signature of Hematologic Malignancies","volume":"49","author":"Allegra","year":"2016","journal-title":"Leuk. Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Stillwell, W. (2016). Introduction to Biological Membranes. An Introduction to Biological Membranes Composition Structure and Function, Elsevier.","DOI":"10.1016\/B978-0-444-63772-7.00001-4"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jnutbio.2012.03.003","article-title":"Nutrition and Epigenetics: An Interplay of Dietary Methyl Donors, One-Carbon Metabolism and DNA Methylation","volume":"23","author":"Anderson","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hon.2752","article-title":"Prognostic Impact of B-Vitamins Involved in One-Carbon Metabolism in Patients with Diffuse Large B-Cell Lymphoma","volume":"38","author":"Cao","year":"2020","journal-title":"Hematol. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, Metabolism, and Cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Korac, P., Dotlic, S., Matulic, M., Petranovic, M.Z., and Dominis, M. (2017). Role of MYC in B Cell Lymphomagenesis. Genes, 8.","DOI":"10.3390\/genes8040115"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of Cancer Cell Metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a Metabolic Gene Regulatory Network Downstream of MTOR Complex 1","volume":"39","author":"Yecies","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/fon.10.11","article-title":"Fatty Acid Synthase as a Potential Therapeutic Target in Cancer","volume":"6","author":"Flavin","year":"2010","journal-title":"Future Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2006-06-028092","article-title":"Rapamycin Is Efficacious against Primary Effusion Lymphoma (PEL) Cell Lines in Vivo by Inhibiting Autocrine Signaling","volume":"109","author":"Sin","year":"2007","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","article-title":"Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma","volume":"22","author":"Caro","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_76","first-page":"995","article-title":"Tonic B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma","volume":"130","author":"Havranek","year":"2017","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature11066","article-title":"AMPK Regulates NADPH Homeostasis to Promote Tumour Cell Survival during Energy Stress","volume":"485","author":"Jeon","year":"2012","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.seminhematol.2015.01.008","article-title":"B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma","volume":"52","author":"Young","year":"2015","journal-title":"Semin. Hematol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cell.2014.03.052","article-title":"Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer","volume":"157","author":"Cunningham","year":"2014","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer Metabolism: A Therapeutic Perspective","volume":"14","author":"Pestell","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrclinonc.2014.51","article-title":"Standing the Test of Time: Targeting Thymidylate Biosynthesis in Cancer Therapy","volume":"11","author":"Wilson","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/0008-5472.CAN-09-3556","article-title":"Rethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism","volume":"70","author":"Dang","year":"2010","journal-title":"Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cmet.2011.06.011","article-title":"Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear Reprogramming","volume":"14","author":"Folmes","year":"2011","journal-title":"Cell Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2006-04-016907","article-title":"Role of Phosphatidylinositol 3\u2032-Kinase\/AKT Pathway in Diffuse Large B-Cell Lymphoma Survival","volume":"108","author":"Uddin","year":"2006","journal-title":"Blood"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2006.06210.x","article-title":"Mammalian Target of Rapamycin Inhibition Induces Cell Cycle Arrest in Diffuse Large B Cell Lymphoma (DLBCL) Cells and Sensitises DLBCL Cells to Rituximab","volume":"134","author":"Wanner","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/leu.2010.154","article-title":"The Dual PI3K\/MTOR Inhibitor, NVP-BEZ235, Is Efficacious against Follicular Lymphoma","volume":"24","author":"Bhende","year":"2010","journal-title":"Leukemia"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5732\/cjc.013.10057","article-title":"Targeting the PI3K-AKT-MTOR Singnaling Network in Cancer","volume":"32","author":"Khan","year":"2013","journal-title":"Chin. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMcibr043143","article-title":"Breast Cancer\u2014Loss of PTEN Predicts Resistance to Treatment","volume":"351","author":"Pandolfi","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1158\/0008-5472-CAN-04-3913","article-title":"PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma","volume":"65","author":"Saal","year":"2005","journal-title":"Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1074\/jbc.M412038200","article-title":"Regulated Association of Protein Kinase B\/Akt with Breast Tumor Kinase","volume":"280","author":"Zhang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1758834014530023","article-title":"The PI3K\/AKT\/MTOR Pathway in Breast Cancer: Targets, Trials and Biomarkers","volume":"6","author":"Paplomata","year":"2014","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1368-7646(02)00120-6","article-title":"Activation of the PI3K\/Akt Pathway and Chemotherapeutic Resistance","volume":"5","author":"West","year":"2002","journal-title":"Drug Resist. Updates"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","article-title":"PI3K\/Akt and Apoptosis: Size Matters","volume":"22","author":"Franke","year":"2003","journal-title":"Oncogene"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.it.2014.11.005","article-title":"Regulation of T Cells by MTOR: The Known Knowns and the Known Unknowns","volume":"36","author":"Pollizzi","year":"2015","journal-title":"Trends Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB Signaling: Navigating Downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.neo.2018.03.002","article-title":"Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma","volume":"20","author":"Wang","year":"2018","journal-title":"Neoplasia"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1305656110","article-title":"PTEN Loss Defines a PI3K\/AKT Pathway-Dependent Germinal Center Subtype of Diffuse Large B-Cell Lymphoma","volume":"110","author":"Pfeifer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3579","article-title":"Disrupting Proton Dynamics and Energy Metabolism for Cancer Therapy","volume":"13","author":"Parks","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1007\/s00259-014-2826-3","article-title":"FDG PET\/CT Methodology for Evaluation of Treatment Response in Lymphoma: From \u201cGraded Visual Analysis\u201d and \u201cSemiquantitative SUVmax\u201d to Global Disease Burden Assessment","volume":"41","author":"Basu","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00259-014-2822-7","article-title":"Pretherapy Metabolic Tumour Volume Is an Independent Predictor of Outcome in Patients with Diffuse Large B-Cell Lymphoma","volume":"41","author":"Sasanelli","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Al Tabaa, Y., Bailly, C., and Kanoun, S. (2021). FDG-PET\/CT in Lymphoma: Where Do We Go Now?. Cancers, 13.","DOI":"10.3390\/cancers13205222"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-030-65768-0_7","article-title":"Non-Hodgkin Lymphoma Metabolism","volume":"1311","author":"Kirsch","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nature13611","article-title":"Oncogene Ablation-Resistant Pancreatic Cancer Cells Depend on Mitochondrial Function","volume":"514","author":"Viale","year":"2014","journal-title":"Nature"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1038\/oncsis.2015.46","article-title":"Energy Disruptors: Rising Stars in Anticancer Therapy?","volume":"5","author":"Bost","year":"2016","journal-title":"Oncogenesis"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence That Metformin Exerts Its Anti-Diabetic Effects through Inhibition of Complex 1 of the Mitochondrial Respiratory Chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem. J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","article-title":"Metformin Inhibits Hepatic MTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex","volume":"25","author":"Howell","year":"2017","journal-title":"Cell Metab."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","article-title":"Metformin, Independent of AMPK, Induces MTOR Inhibition and Cell-Cycle Arrest through REDD1","volume":"71","author":"Sahra","year":"2011","journal-title":"Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin Inhibits Mammalian Target of Rapamycin-Dependent Translation Initiation in Breast Cancer Cells","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1038\/cddis.2012.13","article-title":"Therapeutic Metformin\/AMPK Activation Blocked Lymphoma Cell Growth via Inhibition of MTOR Pathway and Induction of Autophagy","volume":"3","author":"Shi","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2016.02.018","article-title":"MTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells","volume":"29","author":"Pusapati","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2006.04.023","article-title":"Attenuation of LDH-A Expression Uncovers a Link between Glycolysis, Mitochondrial Physiology, and Tumor Maintenance","volume":"9","author":"Fantin","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1073\/pnas.1106123108","article-title":"CD147 Subunit of Lactate\/H+ Symporters MCT1 and Hypoxia-Inducible MCT4 Is Critical for Energetics and Growth of Glycolytic Tumors","volume":"108","author":"Chiche","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI78239","article-title":"Compensatory Glutamine Metabolism Promotes Glioblastoma Resistance to MTOR Inhibitor Treatment","volume":"125","author":"Tanaka","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2015-01-621870","article-title":"Targeting Glutaminolysis Has Antileukemic Activity in Acute Myeloid Leukemia and Synergizes with BCL-2 Inhibition","volume":"126","author":"Jacque","year":"2015","journal-title":"Blood"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1073\/pnas.1507228112","article-title":"MYC Oncogene Overexpression Drives Renal Cell Carcinoma in a Mouse Model through Glutamine Metabolism","volume":"112","author":"Shroff","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"93","DOI":"10.21037\/tcr.2017.01.08","article-title":"The Role of Novel Immunotherapies in Non-Hodgkin Lymphoma","volume":"6","author":"Pishko","year":"2017","journal-title":"Transl. Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"ltab001","DOI":"10.1093\/immadv\/ltab001","article-title":"Upcoming Immunotherapeutic Combinations for B-Cell Lymphoma","volume":"1","author":"Greve","year":"2021","journal-title":"Immunother. Adv."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating Metabolic Pathways to Enhance Antitumour Immunity and Immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_122","unstructured":"Luo, Y. (2020). A Novel Molecular Classification of Diffuse Large B Cell Lymphoma Based on Metabolism-Related Genes. BMC Cancer."},{"key":"ref_123","first-page":"1546","article-title":"How to Differentiate Pseudoprogression from True Progression in Cancer Patients Treated with Immunotherapy","volume":"9","author":"Ma","year":"2019","journal-title":"Am. J. Cancer Res."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/2\/394\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:13:30Z","timestamp":1760134410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/2\/394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":123,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["diagnostics12020394"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12020394","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]}}}